Klcm Advisors, Inc. Sorrento Therapeutics, Inc. Transaction History
Klcm Advisors, Inc.
- $792 Million
- Q2 2024
A detailed history of Klcm Advisors, Inc. transactions in Sorrento Therapeutics, Inc. stock. As of the latest transaction made, Klcm Advisors, Inc. holds 30,000 shares of SRNE stock, worth $9,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,000
Previous 30,000
-0.0%
Holding current value
$9,900
Previous $9,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SRNE
# of Institutions
13Shares Held
5.48MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA5.22MShares$1.72 Million1.01% of portfolio
-
Swisspartners Ltd. Vaduz, N2110KShares$36,3000.12% of portfolio
-
Lattice Capital Management, LLC51.8KShares$17,0940.01% of portfolio
-
Slate Stone Wealth, LLC21.4KShares$7,0720.0% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO20.5KShares$6,7650.0% of portfolio
About Sorrento Therapeutics, Inc.
- Ticker SRNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 449,952,000
- Market Cap $148M
- Description
- Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...